Post-bariatric hypoglycaemia is an increasingly recognised complication of bariatric surgery, manifesting particularly after Roux-en-Y gastric bypass. While hyperinsulinaemia is an established pathophysiological feature, the role of counter-regulation remains unclear. We aimed to assess counter-regulatory hormones and glucose fluxes during insulin-induced postprandial hypoglycaemia in patients with post-bariatric hypoglycaemia after Roux-en-Y gastric bypass vs surgical and non-surgical control individuals. In this case-control study, 32 adults belonging to four groups with comparable age, sex and BMI (patients with post-bariatric hypoglycaemia, Roux-en-Y gastric bypass, sleeve gastrectomy and non-surgical control individuals) underwent a po...
Introduction Hyperglucagonemia is a key pathophysiological driver of type 2 diabetes. Although Roux-...
Hypoglycaemia after gastric bypass can be severe, but is uncommon, and is sometimes only revealed th...
AIMS: To compare directly the impact of glucagon-like peptide-1 secretion on glucose metabolism in i...
Aims/hypothesis Post-bariatric hypoglycaemia is an increasingly recognised complication of bariatri...
Aims/hypothesis: Postprandial hypoglycaemia (PPHG) is a complication of Roux-en-Y gastric bypass (RY...
BACKGROUND Despite the increasing prevalence of postbariatric hypoglycemia (PBH), a late metaboli...
Objective Roux-en-Y Gastric Bypass (RYGB) surgery is currently the most effective treatment for diab...
Objective: Postprandial hyperinsulinemic hypoglycemia with neuroglycopenia is an increasingly recog...
Context: Postprandial hypoglycemia (PPHG) is a recognized complication of Roux-en-Y gastric bypass (...
BackgroundChanges in the multiple mechanisms that regulate glucose metabolism after gastric bypass (...
PURPOSE: Post-bariatric hypoglycemia is a complication of bariatric surgery, especially Roux-en-Y ga...
BACKGROUND: Bariatric surgery markedly improves glucose homeostasis in patients with type 2 diabetes...
BACKGROUND: Altered enteroendocrine hormone responses are widely believed to underlie the beneficial...
While bariatric surgery can improve glycemia in type 2 diabetes (T2D), it can also result in severe ...
OBJECTIVE: Roux-en-Y gastric bypass (RYGB) is an effective way to induce sustainable weight loss and...
Introduction Hyperglucagonemia is a key pathophysiological driver of type 2 diabetes. Although Roux-...
Hypoglycaemia after gastric bypass can be severe, but is uncommon, and is sometimes only revealed th...
AIMS: To compare directly the impact of glucagon-like peptide-1 secretion on glucose metabolism in i...
Aims/hypothesis Post-bariatric hypoglycaemia is an increasingly recognised complication of bariatri...
Aims/hypothesis: Postprandial hypoglycaemia (PPHG) is a complication of Roux-en-Y gastric bypass (RY...
BACKGROUND Despite the increasing prevalence of postbariatric hypoglycemia (PBH), a late metaboli...
Objective Roux-en-Y Gastric Bypass (RYGB) surgery is currently the most effective treatment for diab...
Objective: Postprandial hyperinsulinemic hypoglycemia with neuroglycopenia is an increasingly recog...
Context: Postprandial hypoglycemia (PPHG) is a recognized complication of Roux-en-Y gastric bypass (...
BackgroundChanges in the multiple mechanisms that regulate glucose metabolism after gastric bypass (...
PURPOSE: Post-bariatric hypoglycemia is a complication of bariatric surgery, especially Roux-en-Y ga...
BACKGROUND: Bariatric surgery markedly improves glucose homeostasis in patients with type 2 diabetes...
BACKGROUND: Altered enteroendocrine hormone responses are widely believed to underlie the beneficial...
While bariatric surgery can improve glycemia in type 2 diabetes (T2D), it can also result in severe ...
OBJECTIVE: Roux-en-Y gastric bypass (RYGB) is an effective way to induce sustainable weight loss and...
Introduction Hyperglucagonemia is a key pathophysiological driver of type 2 diabetes. Although Roux-...
Hypoglycaemia after gastric bypass can be severe, but is uncommon, and is sometimes only revealed th...
AIMS: To compare directly the impact of glucagon-like peptide-1 secretion on glucose metabolism in i...